Where’s the elephant in the room gone?6 Aug 2020 22:23
Since I’ve been gambling on AML shares the ‘elephant in the room’ has always been the spectre of further fundraising thus dilution.
It happened the other week when AML raised another £150 or so million, and it again raised the possibility of further fundraising in the short term thus more dilution.
With S&P analysts now removing that doubt, well the ‘elephant has left the room’, and the doubt over liquidity has gone with it.
Institutional investors will now start looking at AML to add a little bit of risk to a balanced portfolio, which will bring more investors looking to buy the stock.
I can see a £1 being a realistic short term target, and by short term I mean two weeks time.